MedTrace Logo

Lay-Delivered Behavioral Activation in Senior Centers

NCT04621877 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2024-10-15

No results posted yet for this study

Summary

In response to large numbers of senior center clients who suffer untreated depression and the dearth of geriatric mental health providers, the investigators have simplified Behavioral Activation to be delivered by lay volunteers ("Do More, Feel Better"; DMFB). The focus of Behavioral Activation is to guide clients to reengage in daily pleasant and rewarding activities, and reduce depressive symptoms. If the investigators can show that the lay delivery model has positive impact in comparison to MSW-delivered Behavioral Activation, the investigators will have identified an effective intervention that can be used by a large untapped workforce of older adult volunteers across the nation.

Conditions

Interventions

BEHAVIORAL

Volunteer-delivered Behavioral Activation

Behavioral Activation as delivered by trained volunteers

BEHAVIORAL

Master's level clinician-delivered Behavioral Activation

Behavioral Activation as delivered by trained master's level clinicians

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of South Florida

    collaborator OTHER

  • Weill Medical College of Cornell University

    collaborator OTHER

  • University of Washington

    lead OTHER

Principal Investigators

  • Patrick J Raue, PhD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-27
Primary Completion
2025-09-30
Completion
2025-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04621877 on ClinicalTrials.gov